Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which form of a drug is absorbed most rapidly?

Aqueous solution. The rate of drug absorption is primarily governed by the physical state of the dosage form. For a drug to be absorbed across biological membranes, it must first be in a molecularly dispersed state (solution). 1. Why Aqueous Solution is Correct: In an aqueous solution, the drug is already dissolved. It bypasses the time-consuming steps of disintegration (breaking down of solid forms) and dissolution (solubilizing the particles). Since the drug molecules are immediately available for passive diffusion or transport across the gastrointestinal mucosa, aqueous solutions exhibit the fastest absorption rate among the given options [1]. 2. Analysis of Incorrect Options: * Suspension (B): This consists of finely divided solid particles dispersed in a liquid. While faster than a tablet, it still requires the particles to undergo dissolution before absorption can occur. * Oily Solution (C): Drugs in oily vehicles are absorbed more slowly than aqueous ones because they must first partition out of the oil phase into the aqueous physiological fluids. In clinical practice, oily solutions are often used as "depot" injections to provide sustained release [1]. * Solid Form (D): This is the slowest. A tablet or capsule must first undergo disintegration into granules, then deaggregation into fine particles, and finally dissolution. This multi-step process significantly delays the onset of absorption [1]. NEET-PG High-Yield Pearls: * Rate-limiting step: For most poorly soluble drugs, dissolution is the rate-limiting step in absorption. * Bioavailability Hierarchy: Aqueous Solution > Suspension > Capsule > Tablet > Sustained Release [1]. * pH Partition Hypothesis: Only the unionized, lipid-soluble form of a drug crosses biological membranes efficiently. While aqueous solutions are absorbed fastest due to physical state, the drug's pKa and the local pH determine the fraction available for absorption [1].

Q: Steady state concentration of a drug is achieved in how many half-lives?

4-5 half-lives. ### Explanation **Concept of Steady State Concentration ($C_{ss}$)** Steady state is reached when the rate of drug administration equals the rate of drug elimination. In first-order kinetics, the time required to reach steady state depends solely on the drug's **half-life ($t_{1/2}$)** and is independent of the dose or frequency of administration [1]. **Why 4-5 half-lives is correct:** The accumulation of a drug follows a predictable mathematical curve [3]. After each half-life, the drug concentration reaches a specific percentage of the ultimate steady state: * 1 $t_{1/2}$: 50% of $C_{ss}$ * 2 $t_{1/2}$: 75% of $C_{ss}$ * 3 $t_{1/2}$: 87.5% of $C_{ss}$ * **4 $t_{1/2}$: 93.75% of $C_{ss}$** * **5 $t_{1/2}$: 96.875% of $C_{ss}$** Clinically, reaching >90% of the target concentration is considered achieving steady state. Therefore, the standard consensus in pharmacology is **4 to 5 half-lives** [2]. **Analysis of Incorrect Options:** * **A & B (2-4 half-lives):** At these stages, the drug has only reached 75–87.5% of its plateau. This is insufficient for a stable therapeutic effect for most drugs. * **D (5-6 half-lives):** While the drug is technically at steady state by this time (>98%), the "4-5" range is the standard academic and clinical benchmark used in competitive exams like NEET-PG. **High-Yield Clinical Pearls for NEET-PG:** 1. **Loading Dose:** If a rapid therapeutic effect is needed (e.g., Lidocaine in arrhythmias), a loading dose is given to bypass the 4-5 half-life delay [2]. 2. **Washout Period:** Similarly, it takes **4-5 half-lives** for a drug to be completely eliminated (97% cleared) from the body after stopping treatment. 3. **Fixed Property:** The time to reach $C_{ss}$ does **not** change if you increase the dose; only the *level* of the concentration changes, not the *time* taken to get there [1].

Q: Which of the following is a known inhibitor of microsomal enzymes?

Sodium valproate. **Explanation:** The correct answer is **Sodium valproate**. This question tests the fundamental pharmacological concept of **Microsomal Enzyme Induction vs. Inhibition**, a high-yield topic for NEET-PG. **1. Why Sodium Valproate is Correct:** Sodium valproate is a potent **microsomal enzyme inhibitor**. It binds to and inhibits the Cytochrome P450 (CYP450) system in the liver. By inhibiting these enzymes, it decreases the metabolism of co-administered drugs (e.g., phenobarbitone, lamotrigine), leading to increased plasma concentrations and potential toxicity. **2. Why the Other Options are Incorrect:** * **Phenobarbitone (A):** A classic, potent enzyme **inducer**. It increases the synthesis of microsomal enzymes, leading to faster metabolism of drugs like warfarin and oral contraceptives. * **Griseofulvin (B):** An antifungal agent known to be an enzyme **inducer**. * **Phenytoin (C):** A widely used antiepileptic that acts as a powerful enzyme **inducer**. **3. High-Yield Clinical Pearls for NEET-PG:** To quickly distinguish between inducers and inhibitors, use these popular mnemonics: * **Enzyme INDUCERS (GPRS Cell Phone):** * **G**riseofulvin * **P**henytoin * **R**ifampicin * **S**moking/St. John's Wort * **C**arbamazepine * **P**henobarbitone * **Enzyme INHIBITORS (VITAMIN K):** * **V**alproate * **I**soniazid * **T**ame (Cimetidine) * **A**miodarone * **M**acrolides (except Azithromycin) * **I**t rona (Ketoconazole/Azoles) * **N**ight (Ritonavir) * **K** (Grapefruit juice) **Key Concept:** Enzyme inhibitors act rapidly (within 24 hours), whereas enzyme induction takes 1–2 weeks to manifest as it requires the synthesis of new enzyme proteins.

Q: An agonist has affinity for which of the following?

The active receptor. ### Explanation **1. Why the Correct Answer (A) is Right:** According to the **Two-State Model** of receptor activation, receptors exist in a dynamic equilibrium between two states: the **Active state (Ra)**, which triggers a biological response, and the **Inactive state (Ri)**, which does not. An **Agonist** is a drug that has a high and selective affinity for the **Active state (Ra)**. By binding preferentially to the active receptor, it shifts the equilibrium toward the Ra state, resulting in a maximal or submaximal biological effect. **2. Why the Other Options are Wrong:** * **Option B (Inactive receptor):** An **Inverse Agonist** has a higher affinity for the **Inactive state (Ri)**. By stabilizing the inactive form, it reduces the constitutive (basal) activity of the receptor, producing an effect opposite to that of an agonist. * **Option C (Both active and inactive receptors):** A **Competitive Antagonist** has equal affinity for both the active and inactive states. Because it binds to both equally, it does not shift the equilibrium; instead, it simply prevents an agonist from binding, resulting in zero intrinsic activity. * **Option D (Neither):** If a drug has no affinity for either state, it cannot bind to the receptor and will not produce any pharmacodynamic effect. **3. High-Yield Clinical Pearls for NEET-PG:** * **Intrinsic Activity (α):** Agonists have an intrinsic activity of **1**; Antagonists have **0**; Inverse agonists have **-1**; Partial agonists have between **0 and 1**. * **Affinity vs. Efficacy:** Affinity is the ability of a drug to *bind* to a receptor, while Efficacy (intrinsic activity) is the ability to *activate* the receptor and produce a response. * **Key Example:** Phenylephrine is a full agonist at α1 receptors, while Propranolol is a competitive antagonist at β receptors.

Q: Absorption of which of the following antimalarial drugs increases with food intake?

Mefloquine. **Explanation:** The correct answer is **Mefloquine**. **Why Mefloquine is correct:** Mefloquine is a highly lipophilic antimalarial drug. The presence of **food, particularly high-fat meals**, significantly enhances its oral bioavailability and rate of absorption. This is a critical pharmacokinetic property because Mefloquine has a very long half-life (approx. 2–3 weeks); ensuring optimal initial absorption is vital for therapeutic efficacy. In clinical practice, patients are advised to take Mefloquine with a meal and a full glass of water to maximize absorption and minimize gastrointestinal irritation. **Why the other options are incorrect:** * **Artesunate (B):** This is a water-soluble artemisinin derivative. It is rapidly absorbed and metabolized to dihydroartemisinin. Its absorption is not significantly dependent on food intake. * **Chloroquine (C):** Chloroquine is almost completely and rapidly absorbed from the gastrointestinal tract regardless of food. While taking it with food may reduce GI upset, it does not significantly increase its bioavailability. * **Amodiaquine (D):** Similar to Chloroquine, it is well-absorbed orally, and its pharmacokinetics are not clinically altered by food intake to the extent seen with Mefloquine. **High-Yield NEET-PG Pearls:** * **Lumefantrine & Halofantrine:** Like Mefloquine, these drugs also show a **marked increase** in absorption when taken with fatty food. (Remember: "Fatty food favors Halofantrine/Lumefantrine/Mefloquine"). * **Atovaquone:** Another antimalarial where fatty food increases bioavailability by up to 3-fold. * **Mefloquine Side Effects:** High-yield for exams are its neuropsychiatric adverse effects (hallucinations, anxiety, and psychosis) and its contraindication in patients with epilepsy or psychiatric disorders.

Q: Which of the following is an enzyme inhibitor?

Cimetidine. **Explanation:** The correct answer is **Cimetidine**. This question tests the fundamental pharmacological concept of Microsomal Enzyme Induction vs. Inhibition. **1. Why Cimetidine is correct:** Cimetidine is a classic **Cytochrome P450 (CYP450) enzyme inhibitor** [1]. It binds to the heme iron of the CYP450 system, reducing the metabolic activity of enzymes like CYP1A2, 2C9, and 2D6 [1]. This leads to decreased metabolism of co-administered drugs (e.g., Warfarin, Theophylline, Phenytoin), potentially causing toxicity [3]. **2. Analysis of Incorrect Options:** * **Phenobarbitone (Option A):** A potent **enzyme inducer**. It increases the synthesis of microsomal enzymes, leading to faster metabolism and reduced efficacy of other drugs. * **Phenytoin (Option B):** Another classic **enzyme inducer**. It is frequently tested in the context of reducing the efficacy of oral contraceptive pills (OCPs). * **CCl4 (Carbon Tetrachloride) (Option D):** This is a **hepatotoxin**, not a therapeutic enzyme inhibitor [2]. While it causes liver damage that impairs metabolism, it is categorized as a toxicological agent that causes centrilobular necrosis [2]. **3. High-Yield Clinical Pearls for NEET-PG:** To remember these for the exam, use these popular mnemonics: * **Enzyme Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. * **Enzyme Inhibitors (VITAMIN K):** **V**alproate, **I**soniazid, **T**erfenadine, **A**miodarone, **M**ethylphenidate, **I**traconazole, **N**itrofurantoin, **K**etoconazole (and **C**imetidine/Ciprofloxacin) [3]. **Note:** Among H2 blockers, Cimetidine has the highest inhibitory potential; newer agents like Famotidine and Ranitidine have negligible effects on CYP450.

Q: What is the ability of the body to eliminate a drug called?

Clearance. ### Explanation **Correct Answer: B. Clearance** **Clearance ($CL$)** is defined as the volume of plasma from which a drug is completely removed per unit of time (e.g., mL/min or L/hr). It represents the body's efficiency in eliminating a drug through various organs, primarily the kidneys and liver. Mathematically, it is expressed as: $$CL = \frac{\text{Rate of elimination}}{\text{Plasma concentration}}$$ Unlike the "rate of elimination," which describes the *amount* of drug removed (e.g., mg/min), clearance describes the *volume* of blood cleared, making it a constant parameter in first-order kinetics. **Why other options are incorrect:** * **A. Volume of Distribution ($Vd$):** This is a proportionality constant relating the total amount of drug in the body to its plasma concentration. it indicates drug distribution into tissues, not elimination. * **C. Steady State:** This is the equilibrium reached when the rate of drug administration equals the rate of drug elimination. It usually takes 4 to 5 half-lives to achieve. * **D. Rate of Elimination:** This refers to the actual mass or amount of drug (e.g., mg) excreted per unit time. In first-order kinetics, this rate changes as the plasma concentration changes, whereas clearance remains constant. **High-Yield NEET-PG Pearls:** 1. **Maintenance Dose Calculation:** Clearance is the most important parameter for determining the maintenance dose ($MD = CL \times C_{ss}$). 2. **First-order vs. Zero-order:** In **First-order kinetics** (most drugs), a constant *fraction* of drug is eliminated (Clearance is constant). In **Zero-order kinetics** (e.g., Ethanol, Phenytoin, Aspirin at high doses), a constant *amount* is eliminated (Clearance decreases as concentration increases). 3. **Total Clearance:** $CL_{total} = CL_{renal} + CL_{hepatic} + CL_{others}$.

Q: Fexofenadine is a metabolic product of which drug?

Terfenadine. **Explanation:** **Correct Answer: D. Terfenadine** **Mechanism and Concept:** Fexofenadine is the active acid metabolite of **Terfenadine**, a second-generation H1-antihistamine. Terfenadine was originally developed as a non-sedating antihistamine; however, it was found to be a "prodrug" that undergoes extensive first-pass metabolism in the liver via the **CYP3A4** enzyme to form Fexofenadine. The clinical significance lies in safety: Terfenadine itself is cardiotoxic. It blocks delayed rectifier potassium channels ($I_{Kr}$) in the heart, leading to **QT interval prolongation** and the potentially fatal arrhythmia, **Torsades de Pointes**. This occurs especially when its metabolism is inhibited (e.g., by erythromycin or ketoconazole). Fexofenadine, however, provides the same antihistaminic benefits without the cardiotoxic effects, leading to the withdrawal of Terfenadine from most markets. **Analysis of Incorrect Options:** * **A. Loratadine:** It is a prodrug, but its active metabolite is **Desloratadine**. * **B. Astemizole:** Like Terfenadine, it was withdrawn due to QT prolongation. Its active metabolite is **Desmethylastemizole**. * **C. Cetirizine:** It is actually the active metabolite of **Hydroxyzine** (a first-generation antihistamine). **High-Yield NEET-PG Pearls:** * **Active Metabolites:** Remember the pairs: Terfenadine $\rightarrow$ Fexofenadine; Loratadine $\rightarrow$ Desloratadine; Hydroxyzine $\rightarrow$ Cetirizine. * **Cardiotoxicity:** Terfenadine and Astemizole are the classic examples of drugs causing Torsades de Pointes via CYP3A4 interactions. * **P-glycoprotein:** Fexofenadine is a substrate for P-glycoprotein, which limits its entry into the CNS, contributing to its highly non-sedating nature.

Question 1

Which form of a drug is absorbed most rapidly?

Accepted Answer

Aqueous solution

Answer

Suspension

Answer

Oily solution

Answer

Solid form

Question 2

Steady state concentration of a drug is achieved in how many half-lives?

Accepted Answer

4-5 half-lives

Answer

2-3 half-lives

Answer

3-4 half-lives

Answer

5-6 half-lives

Question 3

Which of the following is a known inhibitor of microsomal enzymes?

Accepted Answer

Sodium valproate

Answer

Phenobarbitone

Answer

Griseofulvin

Answer

Phenytoin

Question 4

An agonist has affinity for which of the following?

Accepted Answer

The active receptor

Answer

The inactive receptor

Answer

Both active and inactive receptors

Answer

Neither the active nor the inactive receptor

Question 5

Absorption of which of the following antimalarial drugs increases with food intake?

Accepted Answer

Mefloquine

Answer

Artesunate

Answer

Chloroquine

Answer

Amodiaquine

Question 6

Which statement is not true regarding therapeutic drug monitoring (TDM)?

Accepted Answer

TDM is performed when the clinical response to a drug can be easily measured.

Answer

TDM is indicated for drugs with a narrow therapeutic index.

Answer

Digoxin is a drug for which TDM is commonly performed.

Answer

TDM is useful when a drug exhibits erratic pharmacokinetics.

Question 7

Which drug does not follow nonlinear dose-dependent saturation kinetics?

Accepted Answer

Paracetamol

Answer

Salicylates

Answer

Phenytoin

Answer

Ethanol

Question 8

Which of the following is an enzyme inhibitor?

Accepted Answer

Cimetidine

Answer

Phenobarbitone

Answer

Phenytoin

Answer

CCl4

Question 9

What is the ability of the body to eliminate a drug called?

Accepted Answer

Clearance

Answer

Volume of distribution

Answer

Steady state

Answer

Rate of elimination

Question 10

Fexofenadine is a metabolic product of which drug?

Accepted Answer

Terfenadine

Answer

Loratadine

Answer

Astemizole

Answer

Cetirizine

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?